Hypogonadism Completed Phase 2 Trials for Dutasteride (DB01126)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT0039858028-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal MenTreatment
NCT00161421Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral TestosteroneTreatment